Recent Advances with Monoclonal Antibody Drug Targeting for the Treatment of Human Cancer

被引：67

作者：

Koppel, Gary A. ^{[1
]}

机构：

[1] Lilly Res Labs, Indianapolis, IN 46285 USA

来源：

关键词：

D O I：

10.1021/bc00001a002

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

[No abstract available]

引用

页码：13 / 23

页数：11

共 109 条

[1]

ADAMS GP, 1989, CANCER RES, V49, P1707

[2]

BAKER AL, 1988, 3 INT C MON ANT IMM, P93

BAKER, RJ ;

DIAMANTI, CI ;

GOODWIN, DA ;

MEARES, CF .

INTERNATIONAL JOURNAL OF NUCLEAR MEDICINE & BIOLOGY, 1981, 8 (2-3) :159-169

[4]

BARTON R, 1988, 3RD INT C MON ANT IM, P78

[5]

BEIDLER CB, 1988, J IMMUNOL, V141, P4053

[6]

BENACERRAF B, 1985, AM J PATHOL, V120, P334

[7] IMMUNE-RESPONSE GENES OF MAJOR HISTOCOMPATIBILITY COMPLEX [J].

BENACERRAF, B ;

GERMAIN, RN .

[8]

Benacerraf B, 1982, Natl Cancer Inst Monogr, V60, P171

[9]

BENECERRAF B, 1984, ANN IMMUNOL PARIS C, V135, P386

[10]

BLAKEY DC, 1983, RADIOPHARM, V1, P1